Synaptically-released zinc has toxic impact in seizure, ischemia, and trauma, contributing to neuronal injury in all three conditions. Conversely, blockade of the excitotoxic synaptic zinc flux with zinc chelators can reduce neuronal degeneration markers by as much as 80%. We have recently discovered evidence indicating that Nitric Oxide (NO) may control the synaptic release of zinc. Should NO prove to be the controlling factor, this would open completely new avenues for management of zinc-induced brain damage in stroke, ischemia, trauma, and seizure. Moreover, prophylactic control of the Zn2+ toxicity via NO modulation could be used as therapeutic pretreatment in cardiac bypass and carotid endarterectomy procedures. Our pilot data indicate that NO infused into the brain simultaneously depletes presynaptic boutons of their zinc while releasing zinc into dialysates, and we have complementary data from brain slice preparations indicating that NO causes the release of Zn2+ into the bath. Perhaps more compelling, additional data suggest that zinc-induced neuronal injury after head trauma is decreased by up to 50% after blockade of NO* synthesis. The objective of the present proposal is to establish with certainty whether, in fact, NO controls Zn2+ release during excitotoxicity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21NS042882-02
Application #
6615666
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Program Officer
Pancrazio, Joseph J
Project Start
2002-07-23
Project End
2004-05-31
Budget Start
2003-06-01
Budget End
2004-05-31
Support Year
2
Fiscal Year
2003
Total Cost
$148,438
Indirect Cost
Name
Neurobiotex, Inc.
Department
Type
DUNS #
005395335
City
Galveston
State
TX
Country
United States
Zip Code
77550
Giblin, Leonard J; Chang, Christopher J; Bentley, Anthony F et al. (2006) Zinc-secreting Paneth cells studied by ZP fluorescence. J Histochem Cytochem 54:311-6
Frederickson, Christopher J; Giblin 3rd, Leonard J; Rengarajan, Balaji et al. (2006) Synaptic release of zinc from brain slices: factors governing release, imaging, and accurate calculation of concentration. J Neurosci Methods 154:19-29
Frederickson, C J; Giblin, L J; Krezel, A et al. (2006) Concentrations of extracellular free zinc (pZn)e in the central nervous system during simple anesthetization, ischemia and reperfusion. Exp Neurol 198:285-93
Frederickson, Christopher J; Cuajungco, Math P; Frederickson, Cathleen J (2005) Is zinc the link between compromises of brain perfusion (excitotoxicity) and Alzheimer's disease? J Alzheimers Dis 8:155-60; discussion 209-15
Woodroofe, Carolyn C; Masalha, Rafik; Barnes, Katie R et al. (2004) Membrane-permeable and -impermeable sensors of the Zinpyr family and their application to imaging of hippocampal zinc in vivo. Chem Biol 11:1659-66
Hellmich, Helen L; Frederickson, Christopher J; DeWitt, Douglas S et al. (2004) Protective effects of zinc chelation in traumatic brain injury correlate with upregulation of neuroprotective genes in rat brain. Neurosci Lett 355:221-5
Frederickson, Christopher J; Maret, Wolfgang; Cuajungco, Math P (2004) Zinc and excitotoxic brain injury: a new model. Neuroscientist 10:18-25
Nitzan, Yuval B; Sekler, Israel; Frederickson, Christopher J et al. (2003) Clioquinol effects on tissue chelatable zinc in mice. J Mol Med 81:637-44
Frederickson, Christopher J; Suh, Sang W; Koh, Jae-Young et al. (2002) Depletion of intracellular zinc from neurons by use of an extracellular chelator in vivo and in vitro. J Histochem Cytochem 50:1659-62